Mostrando entradas con la etiqueta Norway. Mostrar todas las entradas
Mostrando entradas con la etiqueta Norway. Mostrar todas las entradas

martes, 12 de febrero de 2013

Tuesday's updates on Nordic Business...


Nordic markets are securing bases... 

1) SinterCast secures new order for commercial vehicle series production installation
• Major European commercial vehicle OEM orders SinterCast process control technology
• SinterCast System 3000 to be installed in captive foundry during first quarter of 2013
• Product development and series production of heavy-duty CGI cylinder blocks
(http://www.sintercast.com/corporate)

2) According to Statistics Finland, the wages and salaries sum of the whole economy was 2.3 per cent greater in the past October to December period than in the corresponding period twelve months earlier. In December alone, the wages and salaries sum of the whole economy fell by 0.8 per cent year-on-year. In the October to December period one year ago, the wages and salaries sum grew by 3.4 per cent.

3) Ericsson sign USD 1 billion managed services contract for wireline and wireless networks for North and West India
• Covers 100,000 km of fiber and mobile infrastructure in 11 telecom circles, across North and West of India, including Delhi and Mumbai
• Will lead to productive integration of 5,000 employees by moving them to Ericsson - providing them global opportunities
• Integrated management to deliver world class customer experience using global expertise and bringing in operational efficiencies and cost optimization


4) Swedish Orphan Biovitrum
- Recombinant Fc fusion proteins show potential to transform care by providing long-lasting protection from bleeding with fewer injections than the current standard of care -
Biogen Idec (NASDAQ: BIIB) and Swedish Orphan Biovitrum (Sobi) (STO: SOBI) released data that confirmed the ability of investigational recombinant factors VIII Fc fusion protein (rFVIIIFc) and IX Fc fusion protein (rFIXFc) to provide long-lasting protection from bleeding with fewer injections than are required with the current standard of care for people with hemophilia. The data, from the largest phase 3 registrational studies conducted in hemophilia to date, were presented this week at the 6th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD).


5) Presentation of Telenor's fourth quarter results 2012. Telenor will present its financial results for the fourth quarter 2012 on Wednesday 13 February 2013 at 09:00 hrs Norwegian time/CET. The presentation, which will also be broadcast live over the Internet, will be held in Auditorium Voice, Telenor Expo Visitor Centre at Fornebu near Oslo. The figures will be published on Telenor's website at 07:00 CET. CEO Jon Fredrik Baksaas and CFO Richard Olav Aa will present the results. The presentation will be held in English.

jueves, 7 de febrero de 2013

Statoil: 2012 fourth quarter results


Operating and Financial review

Statoil's (OSE:STL, NYSE:STO) fourth quarter 2012 net operating income was NOK 45.8 billion. In 2012, net operating income was NOK 206.6 billion.

Statoil delivered equity production of 2,004 mboe per day in 2012, increased by 8% from 1,850 mboe per day in 2011. Adjusted earnings increased by 7% to NOK 193.2 billion in 2012, from NOK 179.9 billion in 2011. Statoil achieved an organic reserve replacement ratio (RRR) of 1.1 in 2012.

"2012 was a year of strong strategic and operational progress for Statoil. We grew our production by 8% in 2012, in line with the target we announced in 2011, and we deliver strong earnings growth. We are well underway to deliver profitably on our ambition of producing more than 2.5 million barrels of oil equivalents per day in 2020," says Helge Lund, Statoil's president and CEO.

"Statoil's strategy remains firm. We continue our strong exploration performance, adding more than 1.5 billion barrels in new resources, and we are maturing our high quality project portfolio, including the Johan Sverdrup and Skrugard fields. We continue to manage our balance sheet and enter 2013 from a robust financial position," says Lund.

Statoil's Board of Directors will propose to increase the dividend to NOK 6.75 per share for 2012. This is in line with the company's dividend policy and an increase from NOK 6.50 in 2011.

Statoil maintains its ambition of producing more than 2.5 million barrels of oil equivalents per day by 2020 and estimates organic capital expenditures for 2013 at around USD 19 billion. The company will complete around 50 exploration wells in 2013 with a total exploration activity level at around USD 3.5 billion.


Capital Markets Update

Today, Statoil presents the Capital Markets Update, focusing on our position as the leading oil and gas operator in Norway and the second largest gas supplier to Europe.

"On the Norwegian continental shelf, we announce that we are on track to meet our ambition of producing more than 1.4 million barrels of oil equivalents per day in 2020," says Lund.

"We also announce that Statoil's gas sales in the European markets were all-time high in 2012, at solid prices. We see a strong outlook for the European gas markets and are well positioned to capture value as the markets develop," says Lund.

Statoil also announces today increased gas volumes for the Block 2 discoveries offshore Tanzania to 7-9 Tcf in total recoverable resources.

Fourth quarter results 2012

Statoil's net operating income was NOK 45.8 billion compared to NOK 60.7 billion in the fourth quarter of 2011.

Adjusted earnings were NOK 48.3 billion, compared to NOK 45.9 billion in the fourth quarter of 2011.

Adjusted earnings after tax were NOK 15.1 billion, up from NOK 14.5 billion in the fourth quarter of 2011.

Net income was NOK 13.0 billion compared to NOK 25.5 billion in the fourth quarter of 2011.

martes, 15 de enero de 2013

Guidelines on Hygiene of Food for exporting to Norway

If you export processed food products to Norway, you have to make sure that your products meet all hygiene requirements. The Norwegian legislation on hygiene of foodstuffs is based on EU Regulation (EC) 852/2004. This legislation is based on the methodology of Hazard Analysis and Critical Control Point (HACCP).

The full content of the regulations for download is here:
http://www.cbi.eu/marketintel/Norway%20legislation:%20Hygiene%20of%20foodstuffs%20(HACCP)/159458

Source: CBI - Ministry of Foreign Affairs of Netherlands

jueves, 16 de febrero de 2012

Tromsø - the hotspot for cold biotech The frigid waters off northern Norway provide the perfect environment for marine bio prospecting and biotechnology research of microorganisms, plant and animal cells. Among the recent developments have been the building of a new Barents BioCentre and the establishment of the new cluster BioTech North in Tromsø to help gather the biotech community together. It is all part of Tromsø’s goal to become an international centre for bio marine research and innovation.

The biotech and bio prospecting industry in the Troms area currently employs about 500 people within research and development and 400 in companies. The largest of these is ProBio, a producer of Omega-3 and pharmaceutical products. It is one of several biotech companies in Tromsø, such as Calanus, Marealis and Olivita, which develop health and nutritional products.

Another core competence among some of Tromsø’s biotech companies is within pharmaceutical and diagnostic. Biotech Pharmacon’s subsidiary Marine BioChemicals, for example, has had particular success with developing an enzyme from cod that is used in commercial HIV tests because it increases the specificity and sensitivity of the tests by controlling contamination. 


Barents BioCentre
These are just some of the biotech companies that are expected to possibly avail themselves of the new laboratory facilities at the Barents BioCentre (BBC) next year. 

The BBC is a new joint infrastructure project with the University of Tromsø and the Norwegian Research Institute (Norut). The centre will be established in a new building in Tromsø Science Park by next year. It will include activities from the University of Tromsø, mainly the Norwegian Structural Biological Centre (NorStruct), Norut’s new department for industrial and medical biotechnology, and several biotech companies.

It will cost the Industrial Development Corporation of Norway an investment of NOK 160 million to build the 8,000 square metres addition to Tromsø Science Park, which will comprise mostly laboratories and some office space. Once completed, it will expand the science park to 26,000 square metres and add some 50-100 jobs to the 700 already there, according to Erling Sandsdalen, Norut Tromsø research director and pending BBC managing director.

The centre will benefit from its near proximity to Norway’s national marine biobank Marbank and analyse laboratory Marbio, which are located at Tromsø Science Park. In addition, Norrinova and TTO Nord – Technology Transfer Office will contribute to commercialising the results from the Barents BioCentre.

The main goal of the BBC is to develop the biotech industry in the region. It will serve as a meeting place for industry and academia and provide opportunities for developing new, innovative products and companies. It is expected that some 10-15 biotech companies will be associated with the BBC, meaning they can come and hire access to the labs and personnel for certain periods. It will be both a national and international resource open to any biotech company or institution. 

“We have been working for several years to include international companies in our biotech (community),” said Sandsdalen. “We hope by establishing the BBC, it will be easier…by making it an interesting environment.”

“The benefit is for smaller companies that don’t have access to equipment and personnel,” he added. “Both the university and Norut will have personnel operating in the labs.”

Along with BBC’s members, there are several key players that will be important to developing a strong biotech cluster. These include the University Hospital in Tromsø, BioLab Prosess, Norwegian Institute of Food, Fisheries and Aquaculture Research (Nofima), Centre on Marine Bioactives and Drug Discovery (MabCent), Marbank, funding agencies, the regional forum for biotech and fisheries, and international and national networks.


BioTech North
In a separate recent development, the Tromsø Chamber of Commerce gave the industry a much-needed push by establishing the BioTech North cluster this March. 

The idea for BioTech North started several years ago, when a number of biotech companies in the area felt the need to boost the value creation for the industry, according to Einar Kloosterman, BioTech North manager. The goal is to get more growth and recruit more people, companies and investors to the area.

“A number of companies were the initiators,” said Kloosterman. “They sat together in 2007 and concluded that after 30-40 years of bio tech they had good universities, research and development branch and companies, but it was not enough. The value creation had been less than expected. We want to create a better cluster so that is easy to identify what we are doing and create more value.”

BioTech North will work partly with helping organize workshops and seminars, such as the international conference on marine bio prospecting BioProsp. The next one will take place in Tromsø during February 23-25, 2011. 

BioTech North will function as the promotional arm of the biotech industry, whereas BBC will be the physical gathering point. Kloosterman believes the success of the medical valley in the Øresund region of Sweden and Denmark and the Oslo Cancer Cluster are good examples of how the biotech companies can reap the benefits of working together.

It is estimated that some 25 biotech companies and organizations could be part of Tromsø’s biotech cluster. These would include those involved in bio prospecting, such as Marbio, Marbank and MabCent, a research-based innovation centre within the field of bioactive compounds and drug discovery based on bioactives from marine organisms. 

“In the end, what we want to have is that companies here get more growth, recruit more people, get more companies to the area, and make it an interesting area to do more investments,” said Kloosterman.


Original author: Norway Exports 

miércoles, 16 de noviembre de 2011

Increased imports and exports in Norway

In October, the Norwegian trade surplus came to NOK 26.7 billion; a rise of 1.9 per cent from the same period last year.


The export growth was mainly due to higher prices of both crude oil and natural gas. Several commodity groups accounted for the increase in imports.

Exports of goods, excluding ships and oil platforms, came to NOK 70.7 billion in October, while imports reached NOK 44.0 billion. Compared to October 2010, the import and export rose by 7.7 and 5.5 per cent respectively.

The total export volume of crude oil in October; 37.2 million barrels, was the lowest recorded this year. The export value amounted to NOK 23.5 billion, up 6 per cent from October last year, due to higher prices. At the same time, the export value fell 12 per cent from September to October this year.

The export value of natural gas in October came to NOK 17.8 billion; 9 per cent higher than last year, due to rising prices. The exported volume, on the other hand, fell slightly.

The commodity group including machinery and transport equipment, which are our main import articles, showed an increase of 16 per cent in total, amounting to NOK 16.0 billion. While all types of machinery rose, the imports of telecommunications apparatus and equipment fell by 6 per cent, to NOK 1.6 billion. Passenger cars also showed an upturn of 18 per cent, reaching NOK 2.9 billion.

The import value of manufactured goods and miscellaneous manufactured articles accounted for NOK 6.9 billion and NOK 7.2 billion respectively – up 12 and 7 per cent. Amongst manufactured goods, metals and manufactures of metals showed the sharpest growth, while clothing and professional, scientific controlling instruments took the lead among the manufactured articles.

While food and beverages rose, the imports of inedible crude materials and mineral fuels dropped.

2011-11-16

norwaypost.no